KEY HIGHLIGHTS
– Revenue increased by 6.7% to HK$834.6 million
– Spoiled profit grew by 12.5% to HK$465.5 million
– Revenue attributable to fairness shareholders increased by 1.9% to HK$201.1 million amidst a necessary amplify in strategic investments
– Immediate a final dividend of HK7.35 cents per part
– Sustained momentum from core proprietary Chinese medication manufacturers, in conjunction with Po Chai Tablets, Flying Eagle Woodlok Medicated Oil, and Tin Hee Tong Tin Hee Tablets
– Exact double-digit growth in Oncotype DX Breast Recurrence Fetch (a genomic assay kit for early-stage breast cancer)
– Persevered progress in execrable-border e-commerce and digital transformation initiative
HONG KONG, Jun 22, 2026 – (ACN Newswire) – JBM (Healthcare) Dinky (“JBM Healthcare” or the “Firm”; Stock Code: 2161, alongside with its subsidiaries, the “Group”), a leading branded healthcare merchandise marketer and distributor in Hong Kong, on the present time introduced the annual outcomes of the Group for the yr ended 31 March 2026 (“FY2026” or the “Reporting Year”).
JBM Healthcare delivered resilient performance in FY2026 amid a frequently recuperating Hong Kong retail market. The Group’s branded healthcare industrial recorded a 6.7% yr-on-yr amplify in income to HK$834.6 million. Spoiled profit rose 12.5% to HK$465.5 million, driven by an integrated product mix alongside with operational agility. Consolidated profit attributable to fairness shareholders grew 1.9% to HK$201.1 million, amidst a necessary amplify in strategic investments when it comes to industrial acquisitions and ticket-centered media promoting campaigns.
This right growth became underpinned by the stable performance of the Group’s core proprietary Chinese medicines portfolio, effective ticket administration, and strategic initiatives, in conjunction with the mix of Tin Hee Tong Tin Hee Tablets. The outcomes gift the resilience of the Group’s industrial model and its skill to take dangle of structural healthcare trends — equivalent to rising health awareness, an ageing inhabitants, and rising ask for preventive care — whereas navigating a dynamic user ambiance.
Operational Excellence all the intention in which thru Core Segments
The proprietary Chinese medicines phase recorded necessary growth of 15.5%, led by flagship ticket Po Chai Tablets, which benefited from the a hit open of a new sachet pack. The open of this line extension is backed by impactful marketing and marketing campaigns featuring Louis Koo, alongside with an expanded usage indication. Flying Eagle Woodlok Medicated Oil consolidated its market attach apart thru integrated ticket-building initiatives and celeb endorsement. The a hit integration of Tin Hee Tong Tin Hee Tablets marked a key milestone, bettering the Group’s portfolio in ladies’s wellness.
In the branded medicines phase, Ho Chai Kung maintained stable growth momentum thru sustained marketing and marketing initiatives, celeb partnerships, and high-profile sponsorships.
The health and wellness merchandise phase seen portfolio optimisation, leading to an total income decline, offset by tough double-digit growth in Oncotype DX, which persisted to acquire traction amongst early-stage breast cancer sufferers trying for precision genomic checking out.
Advancing Digital and Substandard-Border Initiatives
The Group made right progress in execrable-border e-commerce, with flagship manufacturers performing neatly on main platforms. In conjunction with expanded choices of concentrated Chinese medication granules, the Group evolved its digital transformation efforts thru the open of a new 24/7 online ordering platform for identical outdated Chinese medication (TCM) clinics below its Chinese medication granules (CCMG) industrial, bettering customer ride and operational effectivity.
Mr. Derek Sum, Chairman and CEO of JBM Healthcare, commented: “In a frequently recuperating yet peaceful cautious retail ambiance, we delivered right financial outcomes whereas making vital progress on our strategic priorities. Our flagship manufacturers persisted to be pleased stable user belief, and we successfully integrated Tin Hee Tong into our proprietary Chinese medicines portfolio. We also evolved key initiatives in digital healthcare and execrable-border e-commerce.”
“Having a look forward, we gaze vital alternatives for our proprietary Chinese medicines industrial, which continues to be a key contributor to the Group’s long-term building. Supported by favourable demographic and policy trends in Hong Kong and the Increased Bay Recount, we remain confident in the growth potentialities of the user healthcare sector. With a portfolio of neatly-trusted manufacturers, alongside with a disciplined execution of the growth suggestions, we’re neatly-poised to comprehend the underlying doable of our manufacturers, thereby maximizing trace for our shareholders.”
About JBM (Healthcare) Dinky (Stock Code: 2161)
JBM Healthcare is a Hong Kong-primarily based company that markets and distributes branded healthcare merchandise all the intention in which thru Increased China, Southeast Asia, and diversified pick nations. The Group is a distinctive participant in the field with marketing and marketing ride and heritage in prescribed capsules that prioritises product efficacy and quality to fulfill consumers’ healthcare needs. As a infamous healthcare ticket operator in Hong Kong, the Group carries a huge-ranging portfolio of branded healthcare merchandise comprising branded medicines, proprietary Chinese medicines, and health and wellness merchandise, which embody neatly-recognised household manufacturers equivalent to Po Chai Tablets, Ho Chai Kung Tji Thung San, Tin Hee Tong Tin Hee Tablets, Contractubex, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 Will also just 2021. For added exiguous print about JBM Healthcare, please consult with: www.jbmhealthcare.com.hk
For media inquiries, please contact:
Strategic Financial Family Dinky
Matter: Press open summary
Provide: JBM (Healthcare) Dinky
Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate Files Community
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate Files Community.
